Cloud Capital: Serial SaaS Founders Raise $7.7M to Put CFOs Back in Control of Cloud Spend

Backed by Connect Ventures, Backed Ventures, and Middlegame Ventures, Cloud Capital is redefining how finance teams manage cloud costs, unlocking savings and reducing risk in the $344B cloud infrastructure market.

SAN FRANCISCO and LONDON, April 23, 2025Cloud Capital, a startup founded by repeat SaaS entrepreneurs, has launched out of stealth with $7.7 million in funding to help CFOs regain financial control of their cloud infrastructure. As AI accelerates cloud usage, Cloud Capital is launching the first FinTech platform built for cloud. It helps companies forecast usage, unlock savings, and eliminate the financial risk of long-term commitments.

Founded by Edward Barrow (CEO), Spencer Pingry (CTO), and Zack Liscio (CPO) – the team behind Idio, Zaius, and Naytev – the trio met at Optimizely, where they experienced the complexity of cloud cost management at scale. Together, they’ve overseen $500M+ in cloud costs and built Cloud Capital to fix it.

“We believe cloud infrastructure is the largest broken market in tech,” said Edward Barrow, Co-founder & CEO. “We’ve built the forecasts and lived the pain. We built Cloud Capital to give CFOs the same level of control over cloud that they have across the rest of the P&L.”

The AI Boom Is Driving a $344B Cloud Cost Crisis

Cloud is now the fastest-growing cost in tech. AI is pushing spend to a $344B run-rate by Q4 2024¹, up 20% year-over-year. By 2030, it’s expected to exceed $1 trillion.

Hyperscalers are scaling fast. In 2024, data center capex rose 51% to $455B²—mostly for AI-ready infrastructure. Their model relies on long-term contracts, shifting financial risk to buyers.

Cloud is now the second-largest expense after headcount: 6% – 12% of revenue in SaaS, and up to 30% – 40% in AI-native firms³. 27% of companies are over budget⁴, with up to 40% in savings left on the table². Yet cloud ownership often sits with engineering, leaving finance teams without visibility or control.

“Cloud has always been a massive cost center but, with AI workloads driving usage through the roof, it’s now the least controlled line item on the P&L,” said Zack Liscio, Co-founder & CPO. “CFOs are asked to approve major investments without insight. We built Cloud Capital to give them control.”

“Cloud Capital is shifting the dynamic,” said Spencer Pingry, Co-founder & CTO. “Unlike traditional tools we take a ‘100% FinTech’ approach, treating cloud like a financial asset and quantifying commitment risk. Other tools help engineers save. We help CFOs manage risk.”

Rapid Fundraising and Early Traction

Cloud Capital raised a $2.3M pre-seed round led by Connect Ventures, with top FinTech angels. Three months later, it closed a $5.4M seed led by Backed Ventures and Middlegame Ventures.

“Cloud Capital is tackling one of the most urgent and overlooked problems in tech: the lack of financial control in cloud infrastructure,” said Rory Stirling, Partner at Connect Ventures. “They’ve lived the problem and are building with the clarity that only comes from first-hand experience. They’re not just optimizing costs, they’re reshaping the financial infrastructure of the cloud era.”

Now live, Cloud Capital works with dozens of AI, FinTech, and Cybersecurity startups across North America and Europe – helping CFOs forecast usage, unlock savings, and manage risk without rigid contracts.

About Cloud Capital

Cloud Capital is the first FinTech platform purpose-built for cloud infrastructure, enabling CFOs to forecast, manage, and de-risk cloud spend. Headquartered in the US, Cloud Capital supports high-growth companies across North America and Europe.

¹ Canalys
² Dell’Oro Group
³ Cloud Capital Research
⁴ Flexera 2025 State of the Cloud Report

Logo – https://mma.prnewswire.com/media/2668261/Cloud_Capital_Logo.jpg

SOURCE Cloud Capital Technologies Holdings

HelloSky Announces $5.5M Oversubscribed Seed Round, Crosses $1M ARR and Expands Executive Team

GREENWICH, Conn., April 23, 2025 — HelloSky (formerly Skyminyr), the only talent intelligence platform purpose-built for the executive search industry, today announced the close of a $5.5 million oversubscribed seed round.

The raise includes participation from Caldwell Partners, Karmel Capital, True Capital Partners, Hunt Scanlon Ventures and prominent angel investors from Google and Cisco Systems. The proceeds of the funding will be invested primarily into engineering and go-to-market efforts.

HelloSky has surpassed $1 million in Annual Recurring Revenue (ARR) and expanded its management team to add executives in sales and marketing. Hugh Burnham has joined the company as EVP, Sales and Marketing, and Mike Kelch has joined as VP of Sales.

“As competition for executive talent escalates, organizations will increasingly turn to recruiting partners leveraging AI-driven platforms to gain a strategic edge,” said Scott A. Scanlon, CEO and co-founder of Hunt Scanlon Ventures. “They will lean on recruiters who can tap into precision talent platforms like HelloSky to integrate candidate identification, behavioral analytics, sector mapping, and human capital intelligence all in one place,” he said. “For executive recruiters this means shorter cycle times, more mandates, and unprecedented growth opportunities.”

Purpose-Built for Executive Search

While many AI recruiting platforms have added executive search features as an afterthought, HelloSky was engineered from the ground up with AI and data science tailored specifically for high-stakes executive placements. The platform delivers unmatched precision in identifying candidates with exact-fit experience and qualifications for leadership roles.

Unlike platforms designed for staff-level recruiting, HelloSky offers advanced executive competency smart tags, relationship intelligence and connection pathing, revealing actionable routes to top talent based on deep employment, investment, and education graphs, not just superficial LinkedIn ties.

HelloSky consolidates human capital, company, talent, and investor data into a single AI-powered platform. “With dynamic market mapping, real-time tracking, and its newly launched SmartRank™ technology, HelloSky is changing the game for how executive talent is sourced and evaluated, eliminating the need for multiple disparate costly subscriptions,” said Alex Bates, CEO of HelloSky.

Strong Early Adoption and Industry Recognition

Several of the fastest-growing executive search firms have already adopted HelloSky, including enterprise deployments at Bespoke Partners, Caldwell Partners, Eastward Partners, NU Advisory Partners, and On Partners. Venture capital and private equity firms are also turning to HelloSky to power talent decisions across their portfolios.

“This is a watershed moment for executive search,” said Mr. Bates. “AI is no longer a futuristic concept—it’s a competitive advantage today. Firms that embrace our platform are the fastest growing firms in executive search, achieving better outcomes with higher candidate precision and placement success.”

HelloSky was recently named to the High Performer Quadrant in G2’s ranking of top Talent Intelligence Software.

HelloSky expects to reach profitability by Q4 2025.

To book a demo with HelloSky, please click here.

About HelloSky
HelloSky is a next-generation precision talent intelligence platform purpose-built for executive search. Leveraging cutting-edge AI, data science, and proprietary talent graphs, HelloSky empowers organizations to connect with the right leaders faster and with greater precision than ever possible. For more information, please visit www.hellosky.ai

About Hunt Scanlon
Hunt Scanlon Media has been informing the executive recruiting and senior talent management sector for over 35 years. Our global news and market intelligence data comes in many forms, including daily newswires, talent leadership reports, newsletter briefings, rankings, global executive leadership conferences, and social media alerts.

Contact: Walker Manning
Vice President, Creative Content
[email protected]

Hunt Scanlon Ventures offers a full range of critical M&A solutions to guide founders and management teams to successful transitions and exits. Our advisory team has a singular focus on the human capital markets, assisting clients in M&A strategy development, valuation analysis, sourcing, growth strategy, transition services, and exit planning.

Contact: Drew Seaman
Managing Director
[email protected]

SOURCE Hunt Scanlon Media

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

TOKYO, April 22, 2025 — The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis, in addition to an investment of approximately JPY 15.9 million (USD 0.1 million1) for a drug discovery project for Chagas disease and leishmaniasis.2 

Investment of approximately JPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis
Tuberculosis (TB) remains a serious infectious disease, with approximately 10.8 million cases and 1.25 million deaths reported in 2023, making it the leading causes of death from a single infectious agent.3 The United Nations’ Sustainable Development Goals (SDGs) set a target to end TB by 2030, but achieving this goal requires accurate and accessible diagnostic technologies. Current TB tests face challenges such as low sensitivity, high costs, complexity, and the need for specialized equipment and sputum samples, making them unsuitable for all patients. In particular, children, people with conditions who cannot produce sputum, and those in resource-limited settings often struggle to receive timely diagnoses, causing the continued spread of the disease. To address this issue, the GHIT Fund has decided to invest approximately JPY 679 million (USD 4.5 million1) towards a new TB diagnostic development project by US-based diagnostic developer Fluxus, Inc., 4 in partnership with Fujirebio, Inc., a developer of clinical diagnostics in Japan,4 and Heidelberg University Hospital in Germany.

This project will leverage Fluxus’ cutting-edge ultrasensitive detection technology to develop and validate a urine-based TB biomarker lipoarabinomannan (LAM) assay on its automated benchtop immunoassay analyzer. Additionally, the project will design and develop critical components for a portable, ultrasensitive point-of-care (PoC) system that integrates the urine LAM test. This advanced technology will enable rapid, accurate, and accessible diagnosis across a broader patient population, contributing to improved clinical outcomes and reduced transmission.

In addition, the GHIT Fund will invest approximately JPY 15.9 million (USD 0.1 million1) in a screening project against Chagas disease and leishmaniasis by Kitasato University, Nagasaki University, University of Tokyo, and Drugs for Neglected Diseases initiative (DNDi).

Please refer to Appendix 1 for detailed descriptions on these projects and their development stages.

As of March 31, 2025, the GHIT Fund has invested in 36 projects, including 15 discovery projects, 12 preclinical projects, and 9 clinical trials.5 The total amount of investments since 2013 is JPY 38.2 billion (USD 255 million1) (Appendix 2).

1 USD1 = JPY149.53, the approximate exchange rate on March 31, 2025.
2 These awarded projects were selected and approved as new investments from among proposals to RFP2023-002 and RFP2024-001 for the Product Development Platform and the Screening Platform, which were open for applications from June 2023 to July 2024.
3 WHO: https://www.who.int/news-room/fact-sheets/detail/tuberculosis
4
 Fluxus, Inc. and Fujirebio, Inc. are members of Fujirebio.
5 This number includes projects in the registration phase.

The GHIT Fund is a Japan-based international public-private partnership (PPP) fund that was formed between the Government of Japan, multiple pharmaceutical companies, the Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which afflict the world’s vulnerable and underserved populations. In collaboration with global partners, the GHIT Fund mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases.
https://www.ghitfund.org/en

Appendix 1. Project Details

ID: G2023-204

Project Title

Ultrasensitive Detection of Urine LAM for Point-of-Care Rapid Diagnosis of All Forms
of Tuberculosis

Collaboration

Partners

1. Fluxus, Inc. (USA)

2. Fujirebio, Inc. (Japan)

3. Heidelberg University Hospital (Germany)

Disease

Tuberculosis

Intervention

Diagnostics

Stage

Product Design, Product development

Awarded Amount

JPY 679,783,110 (USD 4.54 million)

Status

New project

Summary

[Project objective]

To develop a prototype portable point-of-care (PoC) system and integrated ultrasensitive
assay for detection of Lipoarabinomannan (LAM) in urine. The test will be benchmarked
to a fully-validated ultrasensitive urine LAM assay being developed on Fluxus’
automated benchtop immunoassay analyzer.

 

[Project design]
The project objectives will be achieved by performing the following Specific Aims: 1)
Complete development and validation of an ultrasensitive urine LAM assay on an
existing benchtop immunoassay analyzer. This essay will be adapted and transferred to a
stable and cost-effective PoC cartridge format. 2) Design and development of critical
components for a portable, ultrasensitive PoC system, with functional cartridge and prototype PoC LAM assay.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/240/en

ID: S2024-122

Project Title

Searching for Chagas disease therapeutic seed compounds from microbial cultures

Collaboration

Partners

1. Kitasato University (Japan)

2. Nagasaki University (Japan)

3. University of Tokyo (Japan)

4. Drugs for Neglected Diseases initiative (DNDi) (Switzerland)

Disease

Chagas disease / Leishmaniasis

Intervention

Drug

Stage

Screening

Awarded Amount

JPY 15,945,864 (USD 106,639)

Status

New project

Summary

[Project objective]

The main objective of our proposed project is to identify novel T. cruzi active scaffolds
meeting GHIT/DNDi hit criteria and amenable for further development by screening
microbial cultured broths with a natural product chemistry approach. We aim at
characterizing at least five T. new chemical templates unprecedently associated with T.
cruzi
activity over an 18-month work period. We will also opportunistically evaluate the
anti-Leishmania donovani activity of any antichagasic agent to be identified in the course
of the project.

 

[Project design]
In this project, three academic institutions (Kitasato University, Nagasaki University, and
the University of Tokyo) and DNDi will utilize their expertise to identify at least five
seed compounds for Chagas disease therapeutics produced by microorganisms in a one-
and-a-half-year research period. The seed compounds for Chagas disease therapeutics to
be identified during the project will also be assessed for their activity against Leishmania
donovani
, which causes visceral leishmaniasis, to verify their drug potential.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/241/en

*All amounts are listed at an exchange rate of USD1 = JPY149.53, the approximate exchange rate on March 31, 2025.

Appendix 2. Investment Overview (as of March 31, 2025)

Investments to date
Total investments: 38.2 billion yen (USD 255 million1)
Total invested projects: 136 (36 active projects and 100 completed projects)

To learn more about the GHIT Fund’s investments, please visit
Investment Overview: https://www.ghitfund.org/investment/overview/en
Portfolio: https://www.ghitfund.org/investment/portfolio/en
Advancing Portfolio: https://www.ghitfund.org/investment/advancingportfolio/en
Clinical Candidates: https://www.ghitfund.org/investment/clinicalcandidates/en 

For more information, contact:
Katy Lenard at +1-301-280-5719 or [email protected]
Mina Ohata at +81-36441-2032 or [email protected]

SOURCE GHIT Fund

Healthee raises $50M to redefine the future of health benefits

NEW YORK, April 22, 2025 — Healthee, the AI-powered platform transforming the health benefits experience, today announced a $50 million Series B funding round led by Key1 Capital, with continued backing from Fin Capital, Glilot Capital Partners, and Group11.

Healthee did not formally launch this raise. Key1 Capital approached the team after tracking the company’s traction, believing in the product’s vision and potential. The round was oversubscribed, reflecting strong conviction from new and existing investors.

This funding follows a breakout year in which Healthee surpassed 15,000 customers, including standout client organizations Instacart, SiriusXM, and Celonis. Healthee has also deepened its AI capabilities and delivered real savings by improving care access to employers and employees.

We’re building the benefits platform the market has been waiting for — something that’s intuitive, comprehensive, and built for real people,” said Guy Benjamin, CEO and Co-founder of Healthee. “The fact that this round came together without us actively seeking it speaks volumes. Our investors see what we see: a massive opportunity to change how employees experience healthcare and how employers deliver it. This funding gives us the resources to accelerate that mission and continue delivering a better, smarter way to navigate benefits.

With fresh capital, Healthee will expand its product suite, scale its go-to-market operations, and double down on delivering intuitive, AI-powered tools for smarter, more accessible health benefits.

About Healthee
Healthee is a leading company in the health tech industry, focused on transforming how employees navigate healthcare and benefits. With a mission to make access to a healthier life effortless, Healthee utilizes AI technology to simplify complex benefits systems, enhancing user experience, cutting costs, and improving care outcomes. The Healthee platform is designed to make healthcare more accessible, personalized, and efficient. For more information, visit Healthee.com or connect with Healthee on LinkedIn, Instagram, Facebook, X, and YouTube.

SOURCE Healthee

Repurchases of shares by EQT AB during week 16, 2025

STOCKHOLM, April 22, 2025Between 14 April 2025 and 17 April 2025 EQT AB (LEI code 213800U7P9GOIRKCTB34) (“EQT”) has repurchased in total 365,000 own ordinary shares (ISIN: SE0012853455).

The repurchases form part of the repurchase program of a maximum of 4,931,018 own ordinary shares for a total maximum amount of SEK 2,500,000,000 that EQT announced on 11 March 2025. The repurchase program, which runs between 12 March 2025 and 16 May 2025, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No 2016/1052.

EQT ordinary shares have been repurchased as follows:

                                   

                                   

Date:

                                   

Aggregated volume
(number of shares):

                                   

Weighted average
share price per day (SEK):

                                   

Aggregated transaction
value (SEK):

                                   

14 April 2025

 

105,000

 

259.5952

 

27,257,496.00

 

                                   

15 April 2025

 

105,000

 

268.0315

 

28,143,307.50

 

                                   

16 April 2025

 

105,000

 

254.7160

 

26,745,180.00

 

                                   

17 April 2025

 

50,000

 

250.3754

 

12,518,770.00

 

                                   

Total accumulated over week 16

 

365,000

 

259.3555

 

94,664,753.50

 

                                   

Total accumulated during the repurchase program

 

2,996,229

 

292.1684

 

875,403,313.52

 

All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of EQT.

Following the above acquisitions and as of 17 April 2025, the number of shares in EQT, including EQT’s holding of own shares is set out in the table below.


                                   

Ordinary shares

                                   

Class C shares1

                                   

Total

                                   

Number of issued shares2

 

1,241,510,911

 

496,056

 

1,242,006,967

 

                                   

Number of shares owned by EQT AB3 

 

62,920,420

 

 

62,920,420

 

                                   

Number of outstanding shares

 

1,178,590,491

 

496,056

 

1,179,086,547

 

1) Carry one tenth (1/10) of a vote
2) Total number of shares in EQT AB, i.e. including the number of shares owned by EQT AB
3) EQT AB shares owned by EQT AB are not entitled to dividends or carry votes at shareholders’ meetings

A full breakdown of the transactions is attached to this announcement.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/repurchases-of-shares-by-eqt-ab-during-week-16–2025,c4138471

The following files are available for download:

Crowdpac Announces Bart Myers as CEO and a New Advisory Board to Leverage a Successful $4M Funding Round

WASHINGTON, April 22, 2025 — Crowdpac, the original platform for political engagement and small-dollar fundraising, announced a new leadership team led by CEO Bart Myers, supported by a highly-regarded Advisory Board. Crowdpac also announced a successful $4 million funding round led by Chris Tavlarides, Crowdpac’s Chairman, who was joined by a syndicate of mission-aligned investors. Crowdpac will use this new capital to expand the company’s digital campaign platform and as it prepares for a major relaunch in the second half of 2025.

Tech pioneer Bart Myers was formerly CEO of Countable and Causes and brings deep experience in political engagement, digital platforms, and civic innovation. His selection signals a new chapter for Crowdpac, one rooted in building modern, scalable infrastructure for campaigns, organizations, and supporters.

“Our country needs a trusted platform to bring Americans together and strengthen our democracy,” said Myers. “As one of the first and the leading platform of its kind, Crowdpac has a strong foundation upon which to build upon so we can meet this moment—and what’s coming next.”

As it moves into its next phase, Crowdpac also announced the creation of a new Advisory Board, featuring leaders across politics, media, and civic innovation:

  • Athan Stephanopoulos is the former President of NowThis and former Chief Digital Officer of CNN, having led some of the most influential digital media brands of the last decade. A longtime innovator in digital storytelling, he brings deep expertise in content strategy, audience growth, and media innovation.
  • Svante Myrick is the President of People for the American Way and the former mayor of Ithaca, New York, where he became the youngest mayor in the city’s history. A nationally recognized civic leader, Myrick brings invaluable insight into grassroots organizing, youth engagement, and movement-building across the country.
  • Winston Lord is a seasoned strategist with a background in technology, communications, and civic engagement. He architected the return of World Series-winning Major League Baseball team The Nationals to Washington, D.C., building coalitions across public and private sectors. As Co-Founder and Chief Evangelist of Venga, he gave restaurants the power to harness data and guest intelligence to drive growth and loyalty.

Jaime Peters, Crowdpac’s Head of Campaigns, will continue to lead engagement with candidates and causes, helping grassroots campaigns raise money, build lists, and connect with voters who matter most.

Tavlarides commented, “Crowdpac brings a unique legacy—bridging the worlds of DC and Silicon Valley—as one of the country’s leading platforms for advocacy and political fundraising. Now with Bart’s and our advisory board’s leadership, we are bringing it back stronger than ever. The timing could not be more urgent. Stay tuned: big, exciting changes are coming this spring. I could not be more excited about the future of this organization.”

About Crowdpac

Crowdpac is a platform built to power people-first political movements. Crowdpac was originally founded by Gisel Kordestani and Steve Hilton, with Reid Hoffman and Conway Ventures as early investors. By combining technology, fundraising tools, and authentic storytelling, Crowdpac enables everyday Americans to support candidates and causes that reflect their values.

SOURCE Crowdpac

Reusables.com Raises $2.6M Round to Tackle $100B+ Packaging Waste Opportunity, Launches University of California

Backed by top Canadian climate tech and B2B SaaS investors in a $2.6M USD oversubscribed seed round, the company is redefining packaging with its “Tap to Reuse” software and globally unique Smart Return Bins.

VANCOUVER, BC, April 22, 2025Reusables.com, the category-defining platform for tech-enabled reuse, today announced its oversubscribed $2.6M USD seed round, co-led by StandUp Ventures and Amplify Capital, with participation from Sandpiper Ventures and Emend Vision Fund. The funding will accelerate the company’s expansion of hardware-enabled SaaS solutions for the circular economy, strengthening its position as the most scalable and effective reuse system on the market.

Founded by Vancouver entrepreneurs Jason Hawkins and Anastasia Kiku, Reusables rapidly expanded its business in 2024 after shifting away from restaurants and doubling-down on its SaaS offering for institutional food service operators. The company is on track to triple this year to multi-million-dollar revenue.

Unlike many reuse startups that struggle to scale with cleaning, inventory and logistics, Reusables has built the only turn-key enterprise reuse system that enables institutional food service operators like universities and hospitals to track reusable food containers and save costs on disposable packaging waste. Their solution is driving unmatched savings and environmental impact by leveraging on-site cleaning infrastructure to avoid transportation emissions and through a smart “Tap to Reuse” system that’s free for customers with no deposits.

“Our approach is simple: make reuse more cost-effective and convenient than waste,” said Jason Hawkins, CEO at Reusables.com. “We’re thrilled to be backed by the best tech and climate investors as we scale real impact, not just optics. Greenwashing won’t solve the waste crisis—technology and execution will.”

The Most Scalable Reuse System—Built for Institutions

Single-use packaging waste is a $100B+ global opportunity, and while other startups have attempted to tackle the problem, most reuse offerings fail due to operational complexity, and low return rates.

Reusables.com has taken a different approach. Its hardware-enabled SaaS platform provides institutional food service operators with a seamless, data-driven ecosystem for reuse. The company’s globally unique Smart Return Bins—now deployed at more than 34 locations—enable 24/7 automated, contamination-free returns, solving one of the biggest barriers to widespread adoption.

University of California Earth Day Roll-Out

In honour of Earth Day 2025, University of California is excited to launch Reusables on their campuses today as they show strong leadership in higher education sustainability. University of California’s roll-out will begin with both their Riverside and UCLA campuses. 

“Our clients reuse over 500,000 containers in just 2 semesters which translates to over 25 tons of packaging waste avoided and over 100 tons of carbon emissions avoided annually. All of that while keeping labour costs constant and saving on single-use packaging and waste management costs.” shared Anastasia Kiku, COO & Cofounder of Reusables.com.

“Reuse isn’t a trend — it’s an inevitability. We believe the winning solutions will be invisible to the end user: seamless, scalable, and smart. That’s exactly what this team has built. With strong traction, a clear go-to-market, and a category-defining product, we’re excited to back their bold vision as institutional leaders like UCLA and UC Riverside join the zero waste mission.” added Meredith Powell from StandUp Ventures.

A World-Class Team with the Experience to Scale

Reusables.com’s leadership combines deep sustainability expertise with high-growth execution. Jason Hawkins previously exited a food tech company and was Head of Business Development for a $100M eGrocery IPO before launching Reusables.com. Anastasia Kiku, a former pro skier turned climate entrepreneur, leads operations and product innovation.

“Driving large-scale decarbonization requires more than breakthrough tech, it also demands the infrastructure and platforms that make sustainable choices effortless and accessible. Reusables is building a system that removes friction, drives adoption, and delivers real impact at scale. We’re proud to support a solution that is as pragmatic as it is visionary in accelerating the circular economy and moving away from single-use plastic.” said Louis Delorme, Principal at Amplify Capital.

The new funding will be used to expand the company’s enterprise partnerships across North America, grow the team, and enhance its hardware-enabled SaaS model to support large-scale foodservice and retail operations. With growing demand from universities, corporate campuses, and major foodservice providers, Reusables.com is building the infrastructure for a waste-free future.

About Reusables

Reusables.com is the leading hardware-enabled SaaS platform powering the circular economy. Its seamless technology and proprietary Smart Return Bins make reusable packaging scalable, trackable, and easy to use. The company works with top universities, corporate campuses, health care facilities and food service operators to eliminate single-use waste at scale.

SOURCE Reusables.com

Ascertain Raises $10 Million in Series A Funding to Scale Agentic AI Platform

Reimagining Operational Workflows for Health Systems, Payers, and Independent Provider Groups

Led by Deerfield Management, with a strategic investment from Northwell Health, the raise will support Ascertain’s vision for combining humans and AI to create the workforce of the future.

NEW YORK, April 22, 2025 — Ascertain, a healthcare technology company empowering care teams with AI, today announced $10 million in Series A funding in a financing round led by Deerfield Management with strategic participation from Northwell Health. The investment will accelerate the growth and expand access to Ascertain’s AI-powered solutions to enable higher quality patient care, faster care journeys, and more cost-efficient care delivery across the healthcare system.

Built for health systems, payers, and independent provider groups, Ascertain’s AI-powered case management solution automates time-consuming workflows, enabling case managers to focus more on improving the quality and efficiency of patient care. By handling administrative tasks such as documentation, prior authorizations, and compliance, Ascertain boosts efficiency and enables previously understaffed teams to operate more effectively. Case managers spend up to 60% of their time on manual administrative tasks, leaving less time for high-impact work such as care planning and managing high-risk patients. Meanwhile, there are over 100,000 open positions for case managers and administrative roles in the US, an acute labor shortage making it difficult for health systems to meet patient needs.

“Ascertain differentiates itself by using artificial intelligence to reimagine healthcare workflows from the ground up, rather than just making existing workflows more efficient,” said Julian Harris, M.D., Operating Partner, Healthcare Services at Deerfield Management. “The company is bringing partners greater efficiency, reduced friction, and new and improved ways to care for patients.”

Ascertain has been generating strong results for Northwell Health, in partnership with its centralized transitions-of-care administration team, by initiating a pilot to process authorizations, showcasing the power of Ascertain to enable nurses, case managers, social workers, and other staff to focus more of their time on patient care rather than administrative tasks.

“At a time when clinicians and team members are faced with increasing administrative burden and manual work, Ascertain’s ability to automate and streamline workflows allows for focus to be redirected towards patients and their families rather than tasks,” said Mark Solazzo, President of Strategic Initiatives and Chief Operating Officer at Northwell Health. “This collaboration has demonstrated that Ascertain’s technology effectively addresses the unique challenges of complex healthcare organizations. Building on the experience with Northwell, Ascertain is well positioned to partner with fellow health systems to drive greater efficiency and improve patient care.”

Northwell Health is a member of the Aegis Digital Consortium, a collaboration of 11 leading health systems to develop and scale AI-enabled technology solutions, such as Ascertain, to healthcare’s most pressing quality, cost, and equity challenges.

Ascertain CEO Mark Michalski, M.D., brings deep experience at the intersection of healthcare and technology from his time at Mass General Brigham, Amazon, Butterfly Network and Hyperfine Research. Under Mark’s leadership, the Ascertain team has refined and adapted their agentic AI solution to be flexible, easy to deploy, and integrated into existing systems and workflows. As the company continues to scale, Mark will continue with Ascertain while also becoming Chief Information Officer at Deerfield Management. Ascertain will move into Cure, Deerfield’s New York City headquarters.

“There’s a critical need to develop and implement AI solutions to improve operational efficiencies, ease the administrative burden on payers and providers, and facilitate information sharing,” said Michalski. “Collaborating with Deerfield, Northwell, and Aegis provides Ascertain access to a range of distribution channels, workflows, and data, which we believe will unlock new levels of efficiency for healthcare workers.”

In pursuing their mission to ensure that all patients receive the right care at the right time, case managers often grapple with fragmented processes and disconnected systems, while facing acute staffing shortages. Ascertain empowers case managers by providing a single interface to manage communications with clinical teams and payers, surfacing the key medical information they need for conversations with patients and their loved ones, and automating time consuming, manual tasks such as form-filling and navigating portals, all to ensure that patients receive the right care at the right time.

About Ascertain
Ascertain, a healthcare technology company empowering care teams with AI, helps health systems, payers, and independent provider groups streamline operations and reduce administrative burden. Customers can either deploy Ascertain Automate, an enterprise software platform that uses agentic AI to automate high-volume administrative workflows, or engage Ascertain’s tech-enabled services, outsourcing entire workflows to Ascertain’s team, which operates the software on their behalf. From prior authorization and eligibility checks to discharge planning and patient scheduling, Ascertain’s AI agents navigate complex systems, interpret unstructured data, and integrate across fragmented platforms — enabling faster throughput, lower costs, and more time for patient care. Ascertain was launched by Northwell Holdings, the for-profit investment arm of Northwell Health, and Aegis Ventures. To learn more, visit www.ascertain.com and follow us on LinkedIn.

About Deerfield Management
Deerfield is an investment management firm committed to advancing healthcare through investment, information, and philanthropy. The Firm works across the healthcare ecosystem to connect people, capital, ideas, and technology in bold, collaborative, and inclusive ways. For more information, please visit www.deerfield.com.

About Northwell Health 
Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals, about 900 outpatient facilities and more than 12,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 88,000+ employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We’re training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on FacebookXInstagram and LinkedIn.

About Aegis Ventures
Aegis Ventures is a next-generation venture studio that partners with entrepreneurs and healthcare industry leaders to originate, launch, and scale transformative companies. Aegis aims to build companies with the capacity for vast impact, with an initial focus on artificial intelligence and digital health. Within these verticals, Aegis targets the creation of companies that leverage technology to better optimize quality, access, and cost, focusing on innovations that promote seamless continuity of care, patient access, and better-informed clinical decision-making. To learn more about Aegis, visit our website and follow us on LinkedIn.

SOURCE Ascertain

AI-Native Startup Adaptive Announces $7 Million Seed Round and New Platform Enabling Anyone to Build Custom Apps

Adaptive, a platform that lets people personalize their computer, secured seed funding from Pebblebed, Jake Paul’s venture capital firm, and Roblox’s founder

SAN FRANCISCO, April 22, 2025Adaptive, a startup that enables non‑coders to create software that personalizes computing with AI, has closed a $7 million seed round and opened its platform to the public.

Leading the round is Pebblebed, with participation from Conviction Partners, Jake Paul’s Anti Fund, Radical Ventures, and David Baszucki, founder and CEO of Roblox.

Adaptive doesn’t just let you spin up isolated apps—it weaves them into a single, living ecosystem where data flows freely from one tool to the next. “The ‘personal computer’ hasn’t really been invented yet,” says co‑founder Dennis Xu. “Why can’t the notes I write in one app power reminders in another? Or the contacts I manage in my CRM feed directly into my invoicing tool? It’s time to build tools that talk to each other, on your terms.”

Adaptive.ai is available today in three tiers:

  • Free: up to 11 apps and 20 AI prompts per week
  • Creator ($20/mo): up to 30 apps and 200 prompts weekly
  • Pro ($100/mo): unlimited apps and prompts

With Adaptive, you can personalize your ecosystem by building things like:

  • Build a real‑time Classroom Dashboard: Link a quiz generator to a student‑progress tracker so scores automatically populate a live leaderboard and gradebook.
  • Automate your Retail Workflow: Combine an inventory monitor, point‑of‑sale interface and reorder tool so low stock levels trigger purchase orders without any manual data entry.
  • Create a Dynamic Portfolio Site: Sync a file‑storage app with a public gallery so every new upload instantly appears online, complete with captions pulled from your design notes.

“When BASIC first made programming accessible, the vision was that people would solve their own problems,” says Keith Adams, Pebblebed co-founder. “Adaptive’s AI engine finally makes that vision real—no code, no fuss, total ownership.”

Visit adaptive.ai to start building your own interconnected apps today.

About Adaptive 
Adaptive brings us one step closer to the truly personal computer. They dissolve the barrier between developers and everyday consumers, empowering all users to take full advantage of their computer’s creative potential.

Multimedia: Brand Video
Even/Odd (Creative Studio & Production Company) and Andy Madeleine (Director)

SOURCE Adaptive